• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Funding Roundup

Lyra Therapeutics closes $100.5M private placement

April 13, 2022 By Sean Whooley

Lyra Therapeutics LYR-210

Lyra Therapeutics (Nasdaq:LYRA) announced today that it closed its previously announced private placement worth $100.5 million. The company announced last week that, in the private placement, investors had the option in the private placement to purchase either shares of Lyra’s common stock at $4.22 per share or, in lieu thereof, pre-funded warrants to purchase shares […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Respiratory Tagged With: Lyra Therapeutics

Diabetes tech startup Ryse Health raises $3.4M

April 12, 2022 By Sean Whooley

Ryse Health Logo

Ryse Health, a startup providing care offerings to diabetes patients, announced today that it raised $3.4 million in seed funding. The company, which has offices in Baltimore and Arlington, Virginia, provides tech-enabled, office-based and virtual care to type 2 diabetes patients. Ryse Health’s platform includes a continuous glucose monitor (CGM) and a custom app to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Ryse Health

Surf Bio raises $16M seed round for polymer-based drug delivery platform, rapid insulin

April 12, 2022 By Sean Whooley

Surf Bio

Surf Bio announced today that it raised $16 million in seed funding to advance its drug delivery offerings for treating diabetes. Palo Alto, California-based Surf Bio plans to use the funds to advance its polymer-based drug delivery platform and accelerate the development of ultra-rapid insulin for treating diabetes. According to a news release, Breakout Ventures […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Surf Bio

Lyra Therapeutics announces $100.5M private placement

April 8, 2022 By Sean Whooley

Lyra Therapeutics LYR-210

Lyra Therapeutics (Nasdaq:LYRA) announced today that it agreed to sell securities in a private placement worth more than $100 million. The company — which develops the XTreo platform designed to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — did not list an […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Otolaryngology Ear, Nose & Throat, Respiratory Tagged With: Lyra Therapeutics

Dexcom’s board approves 4-for-1 forward stock split

March 25, 2022 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) announced today that its board of directors approved a four-for-one forward split of the company’s common stock. San Diego-based Dexcom’s stock split remains contingent upon stockholder approval of a restated certificate of incorporation. Approval of that would increase the number of authorized shares of common stock from 200 million to 800 million. According […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Wall Street Beat Tagged With: Dexcom

DiaMonTech raises $5M for laser-based blood glucose detection system

February 18, 2022 By Sean Whooley

DiaMonTech

DiaMonTech announced today that it raised $5 million to bring its total funding to more than $20 million to date. Berlin, Germany-based DiaMonTech develops a patented, mid-infrared technology platform designed to enable non-invasive blood glucose measurement using pain-free laser-based detection. The platform has ease of use comparable to the fingerprint sensor on a smartphone, according […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring Tagged With: DiaMonTech

Gyroscope Therapeutics to receive investment from Sanofi worth up to $60M

November 8, 2021 By Sean Whooley

Gyroscope Therapeutics

Gyroscope Therapeutics announced today that it received a commitment from Sanofi (NYSE:SNY) to invest up to $60 million. London-based Gyroscope will receive a $40 million investment from Sanofi initially. That $40 million represents a premium to Gyroscope’s previous Series C financing, with the remaining $20 million to be invested contingent on a future qualifying investment […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Funding Roundup, Optical/Ophthalmic, Pharmaceuticals Tagged With: Gyroscope Therapeutics, sanofi

NovaBay prices $15M private placement

November 1, 2021 By Sean Whooley

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals (NYSE:NBY) announced today that it entered into a securities purchase agreement, with proceeds of approximately $15 million. Emeryville, California-based NovaBay’s agreement with certain institutional investors occurred in connection with a private placement of 15,000 shares of a newly created Series B non-voting convertible preferred stock. The Series B preferred stock comes in at […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Optical/Ophthalmic, Pharmaceuticals, Wound Care Tagged With: Dermadoctor, novabay

Better Therapeutics closes SPAC merger, debuts on Nasdaq

October 29, 2021 By Sean Whooley

Better Therapeutics

Better Therapeutics announced today that it completed its merger with Mountain Crest Acquisition Corp and has gone public on the Nasdaq. San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. Last month, the company confirmed its expectations for the $113 million SPAC merger to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Mergers & Acquisitions, Technology, Wall Street Beat Tagged With: Better Therapeutics, Mountain Crest SPAC

Teva announces two offerings worth $7.5 billion, dips on missed Q3 projections

October 27, 2021 By Sean Whooley

Teva

Teva Pharmaceuticals (NYSE:TEVA) shares took a hit today on third-quarter results that fell short of the consensus forecast. TEVA shares were down -4.7% at $8.95 per share in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -0.8%. The Tel Aviv, Israel-based company posted […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, MassDevice Earnings Roundup, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Teva, Teva Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 36
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS